RxDoctor Payments Data

Neha Shah, DO

Physical Medicine & Rehabilitation · Austin, TXNPI 1639599244

Payments from drug & device makers

$1,712in general payments, 2019–2025

Across 75 payments — averaging $22.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merz Pharmaceuticals, LLC$515
  • AbbVie$371
  • Merz North America, Inc.$233
  • Piramal Critical Care$124
  • Medtronic$97
  • Avanir Pharmaceuticals, Inc.$81
  • plus $292 from 9 others

What the payments were for

  • Food & beverage$1,712100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Merz Pharmaceuticals, LLC15$515
AbbVie18$371
Merz North America, Inc.11$233
Piramal Critical Care7$124
Medtronic(2 entities)5$97
Avanir Pharmaceuticals, Inc.4$81
Ipsen Biopharmaceuticals, Inc4$70
Amneal Pharmaceuticals LLC4$65
Saol Therapeutics Inc.1$44
Upsher-smith Laboratories LLC1$28
Otsuka America Pharmaceutical, Inc.1$19
Microtransponder, Inc.1$19
Neuros Medical, Inc.1$17
Boston Scientific1$16
Aimmune Therapeutics, Inc.1$14

How this compares

$1,712 in reported general payments places this provider in the 80th percentile of 651 physical medicine & rehabilitation providers in Texas.

See all physical medicine & rehabilitation providers in Texas

Medicare billing

Part B allowed, 2024
$149,269
Medicare patients
230
Services billed
1,654

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban45$27,802
Baclofen26$675
Gabapentin52$468
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen40$377
Atorvastatin Calcium49$334
Levetiracetam12$305
Methocarbamol39$283
Potassium Chloride19$276
Amlodipine Besylate30$216
ClopidogrelClopidogrel Bisulfate25$208
Pantoprazole Sodium30$180
Losartan Potassium23$175
Carvedilol26$162
Metoprolol Succinate14$157
Tamsulosin Hcl16$142

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Amneal Pharmaceuticals LLCLevothyroxine Sodium$65$11211 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 651 physical medicine & rehabilitation providers in Texas.

Other physical medicine & rehabilitation in Austin

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →